【2h】

Alloantigen-induced specific immunological unresponsiveness.

机译:同种异体抗原诱导的特异性免疫无反应性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

When the immune system encounters alloantigen it can respond in any one of a number of different ways. The choice that is made will take into account factors such as where, when and how the contact with the alloantigen takes place, as well as the environmental conditions that prevail at the time the alloantigen is encountered. Alloantigen administration before transplantation either alone or in combination with therapeutic agents that modulate the functional activity of the responding leucocytes can be a powerful way of inducing specific unresponsiveness to alloantigens in vivo. The molecular mechanisms that influence the way the outcome of the immune response to alloantigen develops, either activation or unresponsiveness to the triggering antigen, hold the key to our ability to manipulate the immune system effectively by exposing it to donor antigen for therapeutic purposes. This review will focus on alloantigen-induced immunological unresponsiveness and how insights into the mechanisms of unresponsiveness have driven the development of novel tolerance-induction strategies that show promise for translation into the clinic in the future.
机译:当免疫系统遇到同种异体抗原时,它可以多种不同方式中的任何一种发生反应。做出的选择将考虑因素,例如与异源抗原的接触位置,时间和方式,以及遇到异源抗原时所处的环境条件。单独或与调节反应性白细胞功能活性的治疗剂组合在移植前施用同种异体抗原可以是在体内诱导对同种抗原的特异性无反应性的有效方法。影响对同种异体抗原的免疫反应结果发展方式的分子机制,是对触发抗原的激活或无反应,是我们通过将其暴露于供体抗原以达到治疗目的而有效操纵免疫系统能力的关键。这篇综述将侧重于同种抗原诱导的免疫学上的无反应性,以及对无反应性机制的洞察力如何推动了新的耐受诱导策略的发展,这些策略显示了将来转化为临床的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号